Bayer and Evotec sign 5 yr research pact for Chronic Kidney Disease

Bayer and Evotec have recently signed a five-year, multi-target research pact with the aim to develop multiple clinical candidates for the treatment of chronic kidney diseases. Both parties will contribute novel drug targets and a comprehensive set of high-quality technology platforms to jointly develop new innovative treatment options for patients, and will share responsibilities during

Continue Reading